Study reveals why almost half of patients opt out of comprehensive cancer testing

Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study led by researchers at the Perelman School of Medicine at the University of Pennsylvania. Concern for uncertainty and potential distress were cited among the most common reasons to refuse testing. —> Read More